To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: C

Can We Eradicate Tuberculosis? A Review of Obstacles to Eliminate the Disease
Aims and Scope:

Carbon Footprint Reduction Strategies for Hospitality Infrastructure
Aims and Scope:
Cardiovascular & Hematological Agents in Medicinal Chemistry
ISSN: 1871-5257 (Print)
eISSN: 1875-6182 (Online)
Aims and Scope:Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth/mini reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.
Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular & hematological drug discovery.
Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular & hematological drug discovery.
Editor-in-Chief:
De-Pei Li Department of Medicine
University of Missouri
Columbia, MO
USA
University of Missouri
Columbia, MO
USA
Indexed in:
Jisc (Formerly: SHERPA/RoMEO), Portico, Scopus, EMBiology, OpenAire, Index Medicus, MEDLINE/PubMed, Cambridge Scientific Abstracts (CSA)/ProQuest, BIOSIS Reviews Reports and Meetings, BIOSIS Previews, Ulrich's Periodicals Directory, Suweco CZ, Scilit, QOAM, PubsHub, Norwegian Register, MediaFinder®-Standard Periodical Directory, JournalTOCs, J-Gate, Google Scholar, Genamics Journal Seek, EMBASE, EBSCO, Dimensions, CNKI Scholar, Chemical Abstracts Service/SciFinder, Cabell's Directory/Journalytics, British Library... View all
Cardiovascular & Hematological Disorders-Drug Targets
ISSN: 1871-529X (Print)
eISSN: 2212-4063 (Online)
Aims and Scope:Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Editor-in-Chief:
Pietro Scicchitano Department of Cardiology
Hospital "F. Perinei"
Bari
Italy
Hospital "F. Perinei"
Bari
Italy
Indexed in:
Portico, Scopus, EMBiology, OpenAire, Index Medicus, MEDLINE/PubMed, Cambridge Scientific Abstracts (CSA)/ProQuest, BIOSIS Reviews Reports and Meetings, BIOSIS Previews, Ulrich's Periodicals Directory, Suweco CZ, Scilit, QOAM, PubsHub, Norwegian Register, MediaFinder®-Standard Periodical Directory, JournalTOCs, J-Gate, Google Scholar, Genamics Journal Seek, EMBASE, EBSCO, Jisc (Formerly: SHERPA/RoMEO), Dimensions, CNKI Scholar, Chemical Abstracts Service/SciFinder, Cabell's Directory/Journalytics, British Library... View all

Caring for the Elderly Patients Living with Dementia with Unconditional Love
Aims and Scope: